GFI Stock Overview

Operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. More details

GFI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NZ$2M)

Highly volatile share price over the past 3 months compared to the NZ market

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Greenfern Industries Limited Competitors

Rua Bioscience

NZSE:RUA

NZ$4.9m

BLIS Technologies

NZSE:BLT

NZ$19.2m

AFT Pharmaceuticals

NZSE:AFT

NZ$299.9m

TILT Holdings

NEOE:TILT

CA$3.9m

Price History & Performance

Summary of share price highs, lows and changes for Greenfern Industries
Historical stock prices
Current Share Price	NZ$0.021
52 Week High	NZ$0.063
52 Week Low	NZ$0.015
Beta	0
1 Month Change	-19.23%
3 Month Change	-12.50%
1 Year Change	-60.38%
3 Year Change	-90.67%
5 Year Change	n/a
Change since IPO	-94.94%

Recent updates

Shareholder Returns

	GFI	NZ Pharmaceuticals	NZ Market
7D	5.0%	-7.8%	1.7%
1Y	-60.4%	-13.3%	6.7%

Return vs Industry: GFI underperformed the NZ Pharmaceuticals industry which returned -13.3% over the past year.

Return vs Market: GFI underperformed the NZ Market which returned 6.7% over the past year.

Price Volatility

Is GFI's price volatile compared to industry and market?
GFI volatility
GFI Average Weekly Movement	11.4%
Pharmaceuticals Industry Average Movement	10.2%
Market Average Movement	4.5%
10% most volatile stocks in NZ Market	8.9%
10% least volatile stocks in NZ Market	3.0%

Stable Share Price: GFI's share price has been volatile over the past 3 months compared to the NZ market.

Volatility Over Time: GFI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

Founded	Employees	CEO	Website
2018	n/a	Elizabeth Plant	gfi.nz

Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.

Greenfern Industries Limited Fundamentals Summary

How do Greenfern Industries's earnings and revenue compare to its market cap?
GFI fundamental statistics
Market cap	NZ$2.40m
Earnings (TTM)	NZ$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is GFI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GFI income statement (TTM)
Revenue	NZ$0
Cost of Revenue	NZ$0
Gross Profit	NZ$0
Other Expenses	NZ$0
Earnings	NZ$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GFI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 02:13
End of Day Share Price	2024/12/24 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Greenfern Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution